Floatz logo

tp53-epha-2-car-dc

TP53 R273H

Chinese PLA General HospitalvaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the TP53 R273H cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2CCC
Glofitamab
The First Affiliated Hospital with Nanjing Medical University
Phase 2CCC
Azacitidine
The First Affiliated Hospital of Xiamen University
Phase 2CCC
cc-5013
The First Affiliated Hospital with Nanjing Medical University
Phase 2CCC

View all 18 →

Same molecule, other indications

tp53-epha-2-car-dc is also rated in:

EphA2 OverexpressionDormant
CC
Indicative ·
43 / 100
View asset →
TP53 R175HDormant
CC
Indicative ·
43 / 100
View asset →
TP53 R248QDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →